Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial (Lancet Respiratory Medicine, 2022)

(untitled) - Montgomery, H; Hobbs, FDR; Padilla, F; Arbetter, D; Templeton, A; Seegobin, S; Kim, K; Campos, JAS; Arends, RH; Brodek, BH; Brooks, D; Garbes, P; et al.